• Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Stallergenes SA

+ Add to Watchlist

GENP:FP

55.2500 EUR 0.2400 0.44%

As of 11:35:00 ET on 07/31/2014.

Snapshot for Stallergenes SA (GENP)

Open: 55.1600 Day's Range: 55.1600 - 56.5000 Volume: 2,726
Previous Close: 55.0100 52wk Range: 51.0100 - 63.4600 1-Yr Rtn: +1.39%

Stock Chart for GENP

No chart data available.
  • GENP:FP 55.2500
  • 1D
  • 1M
  • 1Y
55.0100
Interactive GENP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GENP

Current P/E Ratio (ttm) 18.2705
Estimated P/E(12/2014) 18.9018
Relative P/E vs. CAC 0.7570
Earnings Per Share (EUR) (ttm) 3.0240
Est. EPS (EUR) (12/2014) 2.9230
Est. PEG Ratio -
Market Cap (M EUR) 765.59
Shares Outstanding (M) 13.86
30 Day Average Volume 3,297
Price/Book (mrq) 3.3114
Price/Sale (ttm) 3.0499
Dividend Indicated Gross Yield 1.36%
Cash Dividend (EUR) 0.7500
Dividend Ex-Date 06/03/2014
5 Year Dividend Growth 10.76%
Next Earnings Announcement 03/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GENP

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for GENP

Stallergenes is an international biopharmaceutical company dedicated to the treatment of allergy-related respiratory diseases using allergy immunotherapy. The company is involved in the research and development of therapeutic sublingual immunotherapy tablets.

Christian ChavyChief Executive OfficerPeter BuhlerChief Financial Officer
Robert ZeldinSenior VP:Global Clinical DevRichard LejosneSenior VP:Human Resources
More Company Profile & Key Executives for GENP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil